NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 356 filers reported holding NEKTAR THERAPEUTICS in Q1 2019. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q3 2019 | $3,000 | -75.0% | 160 | -50.8% | 0.00% | – |
Q2 2019 | $12,000 | -47.8% | 325 | -52.2% | 0.00% | – |
Q1 2019 | $23,000 | +15.0% | 680 | +9.7% | 0.00% | – |
Q4 2018 | $20,000 | +1900.0% | 620 | +3000.0% | 0.00% | – |
Q3 2018 | $1,000 | 0.0% | 20 | 0.0% | 0.00% | – |
Q2 2018 | $1,000 | 0.0% | 20 | -71.4% | 0.00% | – |
Q4 2016 | $1,000 | 0.0% | 70 | +25.0% | 0.00% | – |
Q3 2016 | $1,000 | 0.0% | 56 | 0.0% | 0.00% | – |
Q2 2016 | $1,000 | -98.7% | 56 | -99.0% | 0.00% | – |
Q1 2016 | $77,000 | +7600.0% | 5,575 | +9855.4% | 0.00% | – |
Q4 2015 | $1,000 | -96.8% | 56 | -98.0% | 0.00% | – |
Q3 2015 | $31,000 | -13.9% | 2,832 | 0.0% | 0.00% | – |
Q2 2015 | $36,000 | +12.5% | 2,832 | 0.0% | 0.00% | – |
Q1 2015 | $32,000 | -27.3% | 2,832 | 0.0% | 0.00% | – |
Q4 2014 | $44,000 | – | 2,832 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
CM Management, LLC | 50,000 | $160,000 | 0.18% |
TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |